Indication
Akantior is indicated for the treatment of Acanthamoeba keratitis in adults and children from 12 years of age.
Loading your page…
Loading your page…
Acanthamoeba Keratitis
Marketing Authorisation Holder: SIFI SPA
EMA Authorisation: 22/08/2024
INN: polihexanide
AI Drug & Interaction Analysis
Free account required
Ask Osler about Akantior: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.